BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2025 10:33:53 AM | Browse: 78 | Download: 572
 |
Received |
|
2024-10-04 07:12 |
|
Peer-Review Started |
|
2024-10-04 07:12 |
|
First Decision by Editorial Office Director |
|
2024-11-09 19:21 |
|
Return for Revision |
|
2024-11-10 08:16 |
|
Revised |
|
2024-11-21 07:44 |
|
Publication Fee Transferred |
|
2024-12-16 03:49 |
|
Second Decision by Editor |
|
2025-01-08 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-01-08 07:55 |
|
Articles in Press |
|
2025-01-08 07:55 |
|
Edit the Manuscript by Language Editor |
|
2025-01-14 02:29 |
|
Typeset the Manuscript |
|
2025-01-21 02:45 |
|
Publish the Manuscript Online |
|
2025-02-14 10:33 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Basic Study |
| Article Title |
Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cells response
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yang-Yang Ma, Xiao-Hua Wang, Jian-Ying Zeng, Ji-Bing Chen and Li-Zhi Niu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Science and Technology Program of Guangzhou |
202102010077 |
| International Science Foundation of Guangzhou Fuda Cancer Hospital |
Y2020-ZD-03 |
|
| Corresponding Author |
Li-Zhi Niu, Chief Physician, MD, PhD, Department of Oncology, Guangzhou Fuda Cancer Hospital, No. 2 Tangde West Road, Tianhe District, Guangzhou 510665, Guangdong Province, China. niuboshi@fudahospital.com |
| Key Words |
Irreversible electroporation; Pancreatic cancer; Programmed cell death protein 1 blockade; CD8+ T cell; Anticancer immunity |
| Core Tip |
This study highlights the synergistic effect of combining irreversible electroporation with anti-programmed cell death protein 1 therapy in the treatment of subcutaneous pancreatic cancer. The combination significantly enhances T lymphocyte infiltration, elevates key cytokine levels, and promotes CD8+ T cell-mediated immune responses, resulting in a marked reduction in tumor volume. These findings suggest a promising avenue for improving immunotherapy strategies in pancreatic cancer through enhanced local tumor ablation methods. |
| Publish Date |
2025-02-14 10:33 |
| Citation |
Ma YY, Wang XH, Zeng JY, Chen JB, Niu LZ. Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cells response. World J Gastrointest Oncol 2025; 17(3): 101991 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i3/101991.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i3.101991 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
